Zobrazeno 1 - 10
of 24
pro vyhledávání: '"I.V. Goloborodova"'
Autor:
O.D. Ostroumova, I.V. Goloborodova
Publikováno v:
Clinical pharmacology and therapy. 29:73-79
Autor:
D.A. Sychev Sychev, Neurosurgery, Moscow, Russia, O.D. Ostroumova Ostroumova, Polymorbid Pathology, Moscow, Russia, M.V. Klepikova Klepikova, A.I. Kochetkov Kochetkov, T.M. Ostroumova Ostroumova, I.V. Goloborodova Goloborodova, A.P. Pereverzev Pereverzev, I.A. Alyautdinova Alyautdinova, Therapy, Moscow, Russia
Publikováno v:
Pharmateca. :113-126
Publikováno v:
Pharmateca. :108-118
Autor:
Russian Clinical, I.V. Goloborodova Goloborodova, O.D. Ostroumova Ostroumova, Dentistry, Moscow, Russia
Publikováno v:
Pharmateca. :10-21
Publikováno v:
Pharmateca. :11-20
Autor:
T F Guseva, N.Yu. Voevodina, G F Piksina, I.V. Goloborodova, E E Pavleeva, O.D. Ostroumova Ostroumova
Publikováno v:
Системные гипертензии, Vol 15, Iss 2, Pp 55-59 (2018)
In the article questions of prevention of stroke, including repeated ones, are considered. The choice of anticoagulant therapy is discussed in patients with atrial fibrillation and a number of concomitant diseases - coronary artery disease, diabetes
Publikováno v:
Consilium Medicum. 20:8-16
Autor:
O.D. Ostroumova, I.V. Goloborodova
Publikováno v:
Consilium Medicum. 20:74-79
Publikováno v:
Consilium Medicum. 20:23-29
Publikováno v:
Diabetesmetabolic syndrome. 13(1)
According to modern ideas, disorders in the system of hemostasis in cardiovascular diseases are mainly due to an increase in the functional activity of platelets, namely their increased ability to adhere and aggregate. Aim of the research was to eval